Charles Schwab’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $757K | Buy |
187,890
+18,447
| +11% | +$74.3K | ﹤0.01% | 2991 |
|
2025
Q1 | $463K | Hold |
169,443
| – | – | ﹤0.01% | 3108 |
|
2024
Q4 | $720K | Sell |
169,443
-674
| -0.4% | -$2.87K | ﹤0.01% | 3026 |
|
2024
Q3 | $500K | Buy |
170,117
+10,272
| +6% | +$30.2K | ﹤0.01% | 3163 |
|
2024
Q2 | $556K | Buy |
159,845
+2,107
| +1% | +$7.33K | ﹤0.01% | 3150 |
|
2024
Q1 | $450K | Sell |
157,738
-10,595
| -6% | -$30.2K | ﹤0.01% | 3067 |
|
2023
Q4 | $594K | Hold |
168,333
| – | – | ﹤0.01% | 3008 |
|
2023
Q3 | $436K | Buy |
168,333
+8,589
| +5% | +$22.2K | ﹤0.01% | 3089 |
|
2023
Q2 | $629K | Buy |
159,744
+1,632
| +1% | +$6.43K | ﹤0.01% | 2946 |
|
2023
Q1 | $534K | Buy |
158,112
+13,624
| +9% | +$46K | ﹤0.01% | 2927 |
|
2022
Q4 | $517K | Buy |
144,488
+3,614
| +3% | +$12.9K | ﹤0.01% | 2997 |
|
2022
Q3 | $568K | Sell |
140,874
-151
| -0.1% | -$609 | ﹤0.01% | 2965 |
|
2022
Q2 | $629K | Buy |
141,025
+123,296
| +695% | +$550K | ﹤0.01% | 2974 |
|
2022
Q1 | $151K | Sell |
17,729
-350
| -2% | -$2.98K | ﹤0.01% | 3351 |
|
2021
Q4 | $160K | Hold |
18,079
| – | – | ﹤0.01% | 3389 |
|
2021
Q3 | $189K | Hold |
18,079
| – | – | ﹤0.01% | 3335 |
|
2021
Q2 | $190K | Buy |
+18,079
| New | +$190K | ﹤0.01% | 3270 |
|